Manisha Modak

Dr. Manisha Modak


Research Focus & Metrics

Academic Career Length

10Years (2017-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 November 2020 in European Journal of Pharmacology
Verified
Journal Article
Closed access
RDRujuta R. Deshpande
Rujuta R. Deshpande
ATArpita Tiwari
Arpita Tiwari
NNNarendra Nyayanit
Narendra Nyayanit
MMManisha Modak
Manisha Modak

5 September 2017 in Medicines
Verified
Journal Article
Open access
PDF file
APAshwini Patil
Ashwini Patil
MMManisha Modak
Manisha Modak
Background: Plant-derived bioactive compounds are becoming immensely important as potential drugs. Different solvents are being used for extraction of these phytochemicals. Evaluation of biological activities of aqueous plant extracts is important as water soluble compounds would be more beneficial with respect to certification, safety and commercial issues. Oxidative stress is involved in development of many diseases; therefore, antioxidants are now being looked upon as convincing therapeutics against such diseases. Natural antioxidants are in high demand because of their lesser side effects. This study aims to compare the antioxidant activity of aqueous and methanolic extracts of Acacia catechu—a traditional medicinal plant. Methods: The activity was examined using different in vitro systems including radical scavenging activity, lipid peroxidation and inhibition of •OH radical induced DNA damage using standard protocols. Results: Both aqueous and methanolic extracts of Acacia catechu show significant activities with no differences in the efficacies of water and methanol soluble bioactive compounds. Conclusions: Present study revealed that aqueous extract of A. catechu has equal potential to be used as antioxidants as compared to methanolic extract. This can contribute to increased demand of physiologically compatible bioactive compounds of natural origin.

4 June 2021 in Polycyclic Aromatic Compounds
Verified
Journal Article
Closed access
PTPrashant P. Thakare
Prashant P. Thakare
SDSagar Dakhane
Sagar Dakhane
ASAbdullatif N. Shikh
Abdullatif N. Shikh
MMManisha Modak
Manisha Modak
APAshiwini Patil
Ashiwini Patil
PMPravin C. Mhaske
Pravin C. Mhaske
In the search for new lead compounds targeting fungi and bacteria, based on the in silico molecular docking binding affinity analysis against sterol 14-demethylase enzyme, a series of 4-(imidazo[1,2-a]pyridin-2-yl)quinoline (6a-l) have been synthesized by a cyclo condensation reaction of 4-(2-bromoacetyl)quinolin-1-ium bromide (4a-d) with substituted 2-aminopyridine (5a-c). The newly synthesized 4-(imidazo[1,2-a]pyridin-2-yl)quinoline derivatives were characterized by spectroscopic techniques. The imidazo[1,2-a]pyridinyl-quinoline derivatives were studied for ADME analysis and molecular docking against sterol 14-demethylase, enzyme essential in ergostrol biosynthesis in fungi. All compounds were evaluated for in vitro antifungal activity against Candida albicans (NCIM 3100) and Aspergillus niger (ATCC 504) and in vitro antibacterial activity against Escherichia coli (NCIM 2574), Proteus mirabilis (NCIM 2388), Bacillus subtilis (NCIM 2063), Staphylococcus albus (NCIM 2178). Nine 4-(imidazo[1,2-a]pyridin-2-yl)quinoline derivatives 6b, 6d, 6e, 6f, 6g, 6h, 6i, 6j and 6l, reported good antifungal activity against A. niger with MIC 62.5 µg/mL. To substantiate the mode of action compounds 6b, 6e, 6f, 6g and 6h were investigated for ergosterol inhibition assay against A. niger cells sample at 62.5 µg/mL concentration. The sterol inhibition assay analysis revealed that the ergosterol biosynthesis has decreased in the fungal samples treated with the 4-(imidazo[1,2-a]pyridin-2-yl)quinoline derivatives. Thus the substantial antifungal activity of 4-(imidazo[1,2-a]pyridin-2-yl)quinoline derivatives against A. niger suggested that these compounds could aid and assist in the development of lead compounds to treat fungal infections.